Plaquenil (hydroxychloroquine) an dauke da DMARD tsohuwar cutar ( cutar maganin maganin ƙwayar cuta). An fara amfani da Plaquenil a matsayin magani na antimalarial, amma ana amfani dasu don magance wasu yanayi na rheumatic da na autoimmune wadanda basu da alaka da cutar malaria. Kullum, Plaquenil wani zaɓi ne na zafin jiki kamar yadda ake amfani da shi na jiki (amfani da shi kadai) don rashin lafiya na rheumatoid mai cututtuka ko a hade tare da wasu DMARDs don rashin lafiya da matsananciyar cuta.
A bit of History
Asalin antimalarials ya dawo zuwa 1630s a Peru. An samo haushi daga "itacen zazzabi" a ƙunshe da magungunan antimalarial, quinine.A shekarar 1820, likitoci sun tsabtace kullun daga haushi.Daga sauri zuwa 1951, lokacin da akwai wata hujja ta al'ada game da ci gaba a cikin lupus da ciwon wariyar launin fata by WWII Allied troops wadanda suke daukar nau'i mai launi na quinine, wanda ake kira quinacrine, don hana malaria. A tsawon lokaci, FDA-chloroquine ta saki wasu nau'o'in quinine a shekarar 1952 da hydroxychloroquine a shekarar 1955.
Plaquenil yana da dangantaka da illa mai tasiri, daya daga cikin abin da yake damuwa ga mutanen da aka ba da magani. Amfani da lafiya yana taimakawa wajen rage sakamako mai ban sha'awa .
1. Ko da yake Plaquenil wata tsofaffin miyagun ƙwayoyi ne, har yanzu yana samuwa kuma an umarce shi ga wasu mutanen da ke fama da cututtukan zuciya ko wasu cututtuka na rheumatic.
Plaquenil DMARD ne wanda aka tsara shekaru da yawa don magance cututtuka na rheumatoid, lupus, ƙwayoyin cutar rheumatoid yara , da sauran cututtuka na asibiti.
Lokacin da DMARD na farko ya samu izinin FDA a shekara ta 1998, kuma yayin da sauran ilimin halittu ya biyo baya a cikin shekaru masu zuwa, ya bayyana kamar cewa Plaquenil ba zai zama ba. Magungunan har yanzu yana riƙe da wuri a matsayin wani zaɓi na zahiri don wasu mutane, musamman ma a haɗa tare da hanya , ko mutanen da suke da lupus erythematosus.
Plaquenil wani zaɓi ne ga waɗanda suke kokarin gwada kwayoyin halittu, ba za su iya jure wa kwayoyin halitta ba ko kuma tsoron haɗarin tasirin da suka danganci DMARDs.
2. An tsara lakaran a matsayin mai gyaran maganin cuta, a wasu kalmomi, don rage yawan ciwo, rage ƙumburi, da kuma hana lalacewar haɗin gwiwa da nakasa. Ba a san yadda Plaquenil ke aiki ba amma masu bincike sun yi imani cewa Plaquenil yana rikici da sadarwa tsakanin kwayoyin halitta a cikin tsarin tsarin . Daga karshe, ana tunanin su toshe hanyoyin ƙwayar cuta.
3. Farawa na farko na Plaquenil na 200 mg sau biyu a rana ko 400 MG sau ɗaya a rana, ana gudanar da magana, a cikin mutane kimanin kilo 80 ko fiye. Halin da aka saba amfani da shi shine mafi yawan mutanen da ke dauke da Plaquenil, amma yana yiwuwa a kara ko rage kashi bisa ga bukatun mutum. Yana da mahimmanci don kallon yiwuwar cutarwa da kuma guba. Ga mutanen da suke auna kasa da 80 kg, an yi amfani da kashi a kowace rana, har zuwa kimanin 5 MG / kg na nauyin jiki.
4. Labaran kwayoyi ne mai amfani da miyagun ƙwayoyi. Mutanen da suka ɗauki Plaquenil na iya fara lura da inganta bayan wata daya ko biyu. Zai iya ɗauka har zuwa watanni shida kafin a sami cikakkiyar amfani na Plaquenil.
5. Ana da kyau a dakatar da kwanciyar hankali, amma illa mai yiwuwa ne.
Abubuwan da suke da nasaba da labaran da suka haɗa da Plaquenil sun hada da tashin zuciya da zawo. Yin shan magani tare da abinci yana sauke nauyin ga mafi yawan mutane suna shan magani. Abubuwa masu rinjaye na yau da kullum sun haɗa da raunin fata, gashi mai laushi, da rauni. Sakamakon sakamako na musamman na Plaquenil ya ƙunshi sauye-sauyen ra'ayi ko yiwuwar hasara na hangen nesa - sakamako mai mahimmanci wanda ya fi damuwa ga marasa lafiya.
6. Hanyoyin da ke da nasaba da abin da ke faruwa a fannin ilimin (hydroxychloroquine retinopathy), idan aka kama da wuri, na iya inganta bayan dakatar da Plaquenil. Tun da sakamakon sakamako mai zurfi na hangen nesa zai yiwu amma rare, yana da muhimmanci a gare ka ka gaya wa likitanka game da duk wani canji na gani da ka fuskanta.
Doctors suna bayar da shawarar idanun ido a yayin da suke kan Plaquenil, don haka za'a iya kama canje-canjen da wuri. Da zarar an gano abubuwan da suka faru, haɗari ya riga ya faru. Duk da yake yana iya zama mai juyayi idan aka kama da wuri, hydroxychloroquine retinopathy ba koyaushe ba ne.
7. Wasu mutane sun fi sauƙi fiye da wasu zuwa matsalolin hangen nesa tare da Plaquenil. Har ila yau, hangen nesa da aka hade da Plaquenil suna da wuya, amma wasu mutane suna da haɗari wajen bunkasa matsalar. Magunguna masu ƙananan haɗari sun hada da wadanda:
sun dauki matsayi mai yawa na Plaquenil na tsawon shekaru (watau 1000 g na tsawon shekaru 7)
suna da shekaru 60 ko tsufa
suna da girma
da manyan hanta ko koda
suna da cututtukan da suka riga sun kasance, wadanda suka kamu da cutar, ko magunguna
8. Duk wa] anda ke farawa da maganin Lafiya za su yi nazari a asibiti a cikin shekara ta farko. Idan bincike na farko na gwaji na al'ada ne kuma anyi la'akari da mutum ƙananan hadarin, sake gwadawa bazai faru ba har shekaru biyar. Ana bada shawarar cewa marasa lafiya marasa lafiya suna da nazarin ido na shekara-shekara.
9. Wasu kwayoyi zasu iya hulɗa tare da Plaquenil, yana tasirin yadda yake aiki ko haddasa shi ya zama m. Gwa likita game da kowace magani da kari da kake ɗauka.
Drugs wanda zai iya hulɗa tare da Plaquenil sun hada da:
antacids
inxulin botulinum
digoxin
kaolin
magnesium trisilicate
methotrexate
metoprolol
penicillamine
10. Idan kun kasance masu ciki ko la'akari da yin ciki, tattauna Tattaunawa tare da likitoci. Ko da yake an yi la'akari da kwanciyar hankali a yayin da ake ciki, an bada shawarar cewa ana amfani da kulawar haihuwar haihuwa a duk lokacin da ake kula da cutar Plaquenil kuma har zuwa watanni shida bayan an dakatar da magani.
11. An haɗa nauyin plaquenil tare da ƙarin kayan amfani mai amfani a cikin mutanen da ke fama da cutar rheumatic. A cikin mutane da aka yi da Plaquenil a matsayin maganin maganin cutar antirheumatic, an gano magungunan yana da wasu tasiri masu amfani. An gano Plaquenil don inganta bayanan lipid, sarrafa glucose kuma rage haɗari na ciwon sukari, kuma rage haɗarin thrombosis a wasu mutanen da ke cikin haɗari.
Sources:
Cannon, Michael, MD. Hydroxychloroquine (Plaquenil). Kwalejin Amirka na Rheumatology. Updated Maris 2015.
Radis, Charles, DO. Plaquenil: Daga Ciwon Cutar Malaria don Gudanarwa Lupus, RA. Rheumatologist. Mayu 15, 2015.
Nunawa ga Hydroxychloroquine Retinopathy . Bayanin wuri daga Cibiyar Rheumatology na Amirka. Agusta 2016.
Wallace, Daniel, MD. Antimalarial Drugs a Jiyya na Rheumatic cuta. Na zamani. Janairu 10, 2017.